Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Nextech3D.ai Announces First New Customer Win For its AI Powered Photography Studio (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Technology Scientific & Technical Instruments
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Ventripoint joins with GE Healthcare
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(106)
•••
Comment by G1945Von Apr 27, 2021 7:58am
241 Views
Post# 33072879

RE:RE:Ventripoint joins with GE Healthcare

RE:RE:Ventripoint joins with GE Healthcare 8. While there is not much more I can say about the agreement due to confidentiality, I will be holding a Q&A session Tuesday, April 27, 2021 at 1:00 pm EST to make sure we convey the information about this major milestone as completely as we can to our supportive and patient shareholders.  Here is the call-in information:
 
Meeting ID: 892 1242 0293 
Passcode: 553046 
One tap mobile 
+13462487799,,89212420293#,,,,*553046# US (Houston) 
+16465588656,,89212420293#,,,,*553046# US (New York) 
Dial by your location 
        +1 346 248 7799 US (Houston) 
        +1 646 558 8656 US (New York) 
        +1 669 900 9128 US (San Jose) 
        +1 253 215 8782 US (Tacoma) 
        +1 301 715 8592 US (Washington DC) 
        +1 312 626 6799 US (Chicago) 
Meeting ID: 892 1242 0293 
Passcode: 553046 
Find your local number: https://us02web.zoom.us/u/kbtILsakuR
 
Regards,
 
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
TSXV-VPT
519-803-6937
 
 
G1945V
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities